iRhythm price target raised to $135 from $120 at BTIG
BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...
Yahoo Finance8d
BTIG downgrades General Dynamics on Gulfstream supply chain, certification
Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...
Business Wire18d
BTIG to Host Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 11 - 12, 2025
NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...
BTIG Sticks to Its Buy Rating for Insulet (PODD)
BTIG analyst Marie Thibault reiterated a Buy rating on Insulet (PODD – Research Report) yesterday and set a price target of $310.00. The ...
Yahoo Finance1mon
Evolent Health price target lowered to $20 from $29 at BTIG
BTIG lowered the firm’s price target on Evolent Health (EVH) to $20 from $29 but keeps a Buy rating on the shares. The firm notes it was disappointed by the company’s comments around higher ...
Nasdaq2mon
BTIG Initiates Coverage of ImmunityBio (IBRX) with Buy Recommendation
As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...
BTIG上调MercadoLibre目标价至2,500美元，看好第四季度强劲表现
周五，BTIG分析师调整了对MercadoLibre（NASDAQ:MELI）股票的展望，将目标价从此前的2,200美元上调至2,500美元，同时维持买入评级。该股目前交易价格为2,110.47美元，接近52周高点2,161.73美元，年初至今已实现 ...
BTIG upgrades Snowflake to 'buy' on improving demand
BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth.